Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · Real-Time Price · USD
1.090
-0.050 (-4.39%)
At close: Apr 25, 2025, 4:00 PM
1.100
+0.010 (0.92%)
After-hours: Apr 25, 2025, 5:03 PM EDT
PACB Revenue
In the year 2024, Pacific Biosciences of California had annual revenue of $154.01M, down -23.19%. Pacific Biosciences of California had revenue of $39.22M in the quarter ending December 31, 2024, a decrease of -32.79%.
Revenue (ttm)
$154.01M
Revenue Growth
-23.19%
P/S Ratio
1.94
Revenue / Employee
$267,850
Employees
575
Market Cap
324.66M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 154.01M | -46.51M | -23.19% |
| Dec 31, 2023 | 200.52M | 72.22M | 56.29% |
| Dec 31, 2022 | 128.30M | -2.21M | -1.69% |
| Dec 31, 2021 | 130.51M | 51.62M | 65.43% |
| Dec 31, 2020 | 78.89M | -12.00M | -13.20% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 410.06B |
| Johnson & Johnson | 89.33B |
| Merck & Co. | 63.92B |
| AbbVie | 56.33B |
| AstraZeneca | 54.07B |
| Novartis AG | 51.72B |
| Eli Lilly and Company | 45.04B |
| Thermo Fisher Scientific | 42.90B |
PACB News
- 3 days ago - Davos Alzheimer's Collaborative Selects PacBio as Technology Partner for Global Project to Advance Alzheimer's Disease Research in North Africa - GlobeNewsWire
- 16 days ago - PacBio Announces Preliminary First Quarter 2025 Revenue and Reiterates 2025 Revenue Guidance of $155 Million to $170 Million - GlobeNewsWire
- 21 days ago - PacBio Grants Equity Incentive Award to New Employee - GlobeNewsWire
- 4 weeks ago - Pacific Biosciences Names Jim Gibson Chief Financial Officer - Market Watch
- 4 weeks ago - Jim Gibson to join PacBio as Chief Financial Officer - GlobeNewsWire
- 5 weeks ago - Scientists Solve One of Genomics' Biggest Challenges by Using HiFi Sequencing to Distinguish Highly Similar Paralogous Genes - GlobeNewsWire
- 2 months ago - Pacific Biosciences: Uncertain Federal Research Funding Latest Blow For Already-Battered Stock - Seeking Alpha
- 2 months ago - PacBio to Participate in TD Cowen's 45th Annual Health Care Conference - GlobeNewsWire